BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22648732)

  • 1. Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among Black and White women.
    Reding KW; Carlson CS; Kahsai O; Chen CC; McDavid A; Doody DR; Chen C; Ornelas I; Lowe K; Bernstein L; Weiss L; McDonald JA; Simon MS; Strom B; Marchbanks PA; Burkman R; Spirtas R; Liff JM; Malone KE
    Breast Cancer Res Treat; 2012 Jul; 134(2):801-9. PubMed ID: 22648732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
    Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
    Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An admixture scan in 1,484 African American women with breast cancer.
    Fejerman L; Haiman CA; Reich D; Tandon A; Deo RC; John EM; Ingles SA; Ambrosone CB; Bovbjerg DH; Jandorf LH; Davis W; Ciupak G; Whittemore AS; Press MF; Ursin G; Bernstein L; Huntsman S; Henderson BE; Ziv E; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3110-7. PubMed ID: 19843668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.
    Quan L; Gong Z; Yao S; Bandera EV; Zirpoli G; Hwang H; Roberts M; Ciupak G; Davis W; Sucheston L; Pawlish K; Bovbjerg DH; Jandorf L; Cabasag C; Coignet JG; Ambrosone CB; Hong CC
    Int J Cancer; 2014 Mar; 134(6):1408-21. PubMed ID: 23996684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants of estrogen-related genes and breast cancer risk in European and African American women.
    Quan L; Hong CC; Zirpoli G; Roberts MR; Khoury T; Sucheston-Campbell LE; Bovbjerg DH; Jandorf L; Pawlish K; Ciupak G; Davis W; Bandera EV; Ambrosone CB; Yao S
    Endocr Relat Cancer; 2014; 21(6):853-64. PubMed ID: 25228414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of dietary folate, Vitamins B6 and B12 and methionine intake with risk of breast cancer among African American and European American women.
    Gong Z; Ambrosone CB; McCann SE; Zirpoli G; Chandran U; Hong CC; Bovbjerg DH; Jandorf L; Ciupak G; Pawlish K; Lu Q; Hwang H; Khoury T; Wiam B; Bandera EV
    Int J Cancer; 2014 Mar; 134(6):1422-35. PubMed ID: 23996837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study.
    Yao S; Zirpoli G; Bovbjerg DH; Jandorf L; Hong CC; Zhao H; Sucheston LE; Tang L; Roberts M; Ciupak G; Davis W; Hwang H; Johnson CS; Trump DL; McCann SE; Ademuyiwa F; Pawlish KS; Bandera EV; Ambrosone CB
    Breast Cancer Res; 2012 Apr; 14(2):R58. PubMed ID: 22480149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
    Roseland ME; Schwartz K; Ruterbusch JJ; Lamerato L; Krajenta R; Booza J; Simon MS
    Breast Cancer Res Treat; 2017 Aug; 165(1):163-168. PubMed ID: 28547656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race and the prognostic influence of p53 in women with breast cancer.
    Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
    Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry.
    Ambrosone CB; Young AC; Sucheston LE; Wang D; Yan L; Liu S; Tang L; Hu Q; Freudenheim JL; Shields PG; Morrison CD; Demissie K; Higgins MJ
    Oncotarget; 2014 Jan; 5(1):237-48. PubMed ID: 24368439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome.
    Lund MJ; Mosunjac M; Davis KM; Gabram-Mendola S; Rizzo M; Bumpers HL; Hearn S; Zelnak A; Styblo T; O'Regan RM
    Cancer; 2012 Feb; 118(3):788-96. PubMed ID: 21720988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
    Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
    JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic susceptibility loci for subtypes of breast cancer in an African American population.
    Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-negative breast cancers are increased in black women regardless of age or body mass index.
    Stead LA; Lash TL; Sobieraj JE; Chi DD; Westrup JL; Charlot M; Blanchard RA; Lee JC; King TC; Rosenberg CL
    Breast Cancer Res; 2009; 11(2):R18. PubMed ID: 19320967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of triple-negative tumors in an urban cancer center.
    Lund MJ; Butler EN; Bumpers HL; Okoli J; Rizzo M; Hatchett N; Green VL; Brawley OW; Oprea-Ilies GM; Gabram SG
    Cancer; 2008 Aug; 113(3):608-15. PubMed ID: 18484596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
    Lund MJ; Trivers KF; Porter PL; Coates RJ; Leyland-Jones B; Brawley OW; Flagg EW; O'Regan RM; Gabram SG; Eley JW
    Breast Cancer Res Treat; 2009 Jan; 113(2):357-70. PubMed ID: 18324472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
    Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
    Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC amplification in subtypes of breast cancers in African American women.
    Naab TJ; Gautam A; Ricks-Santi L; Esnakula AK; Kanaan YM; DeWitty RL; Asgedom G; Makambi KH; Abawi M; Blancato JK
    BMC Cancer; 2018 Mar; 18(1):274. PubMed ID: 29523126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations.
    Miyashita M; Bell JSK; Wenric S; Karaesmen E; Rhead B; Kase M; Kaneva K; De La Vega FM; Zheng Y; Yoshimatsu TF; Khramtsova G; Liu F; Zhao F; Howard FM; Nanda R; Beaubier N; White KP; Huo D; Olopade OI
    Breast Cancer Res; 2023 May; 25(1):58. PubMed ID: 37231433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.